Literature DB >> 11294836

Transcriptional activation by a matrix associating region-binding protein. contextual requirements for the function of bright.

M H Kaplan1, R T Zong, R F Herrscher, R H Scheuermann, P W Tucker.   

Abstract

Bright (B cell regulator of IgH transcription) is a B cell-specific, matrix associating region-binding protein that transactivates gene expression from the IgH intronic enhancer (E mu). We show here that Bright has multiple contextual requirements to function as a transcriptional activator. Bright cannot transactivate via out of context, concatenated binding sites. Transactivation is maximal on integrated substrates. Two of the three previously identified binding sites in E mu are required for full Bright transactivation. The Bright DNA binding domain defined a new family, which includes SWI1, a component of the SWI.SNF complex shown to have high mobility group-like DNA binding characteristics. Similar to one group of high mobility group box proteins, Bright distorts E mu binding site-containing DNA on binding, supporting the concept that it mediates E mu remodeling. Transfection studies further implicate Bright in facilitating spatially separated promoter-enhancer interactions in both transient and stable assays. Finally, we show that overexpression of Bright leads to enhanced DNase I sensitivity of the endogenous E mu matrix associating regions. These data further suggest that Bright may contribute to increased gene expression by remodeling the immunoglobulin locus during B cell development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294836     DOI: 10.1074/jbc.M100836200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.

Authors:  Gergana Dobreva; Julia Dambacher; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

2.  The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development.

Authors:  Carol F Webb; James Bryant; Melissa Popowski; Laura Allred; Dongkoon Kim; June Harriss; Christian Schmidt; Cathrine A Miner; Kira Rose; Hwei-Ling Cheng; Courtney Griffin; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2011-01-03       Impact factor: 4.272

3.  Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription.

Authors:  Josephine A Tidwell; Christian Schmidt; Phillip Heaton; Van Wilson; Philip W Tucker
Journal:  Mol Immunol       Date:  2011-09-28       Impact factor: 4.407

4.  Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.

Authors:  Christian Schmidt; Dongkyoon Kim; Gregory C Ippolito; Hassan R Naqvi; Loren Probst; Shawn Mathur; German Rosas-Acosta; Van G Wilson; Athenia L Oldham; Martin Poenie; Carol F Webb; Philip W Tucker
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

5.  Interferon-α signaling promotes embryonic HSC maturation.

Authors:  Peter Geon Kim; Matthew C Canver; Catherine Rhee; Samantha J Ross; June V Harriss; Ho-Chou Tu; Stuart H Orkin; Haley O Tucker; George Q Daley
Journal:  Blood       Date:  2016-04-19       Impact factor: 22.113

6.  A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes.

Authors:  Dongkyoon Kim; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

7.  The structure of the Dead ringer-DNA complex reveals how AT-rich interaction domains (ARIDs) recognize DNA.

Authors:  Junji Iwahara; Mizuho Iwahara; Gary W Daughdrill; Joseph Ford; Robert T Clubb
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

8.  SMAR1 and Cux/CDP modulate chromatin and act as negative regulators of the TCRbeta enhancer (Ebeta).

Authors:  Ruchika Kaul-Ghanekar; Archana Jalota; L Pavithra; Philip Tucker; Samit Chattopadhyay
Journal:  Nucleic Acids Res       Date:  2004-09-15       Impact factor: 16.971

9.  ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF.

Authors:  Ronald L Chandler; Jennifer Brennan; Jonathan C Schisler; Daniel Serber; Cam Patterson; Terry Magnuson
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

10.  Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer.

Authors:  Danjuan Lin; Gregory C Ippolito; Rui-Ting Zong; James Bryant; Janet Koslovsky; Philip Tucker
Journal:  Mol Cancer       Date:  2007-03-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.